EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma
China38 participantsStarted 2018-12-20
Plain-language summary
the study evaluate the efficacy and safety of EUS-RFA using Habib EUS-RFA catheter with a prospective randomised trial in patients with inoperable PDAC.
Who can participate
Age range20 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients in the age group 20 to 80 years
* A cytological or histological diagnosis of inoperable PDAC based on multidisciplinary review of cross sectional imaging and cytology or histology results.
* Patients who have been deemed unfit for surgical resection of the PDAC subjects who are fit for surgical resection but have declined surgery will also be considered for the study
* PDAC patients presenting with jaundice to be considered after a successful biliary drainage
* Patients ought to be fit enough to be considered for the study (ECOG performance status 0, 1 or 2)
* Patients capable of giving informed consent
Exclusion Criteria:
* Inability to give informed consent
* Pregnancy or breast feeding
* ECOG performance status 3 or 4
* Life expectancy less than 3 months
* Patients with distant metastases or malignant ascites
What they're measuring
1
Change in tumour size as measured on EUS and or CT